<?xml version="1.0" encoding="utf-16"?>
<KEGG.PathwayBrief xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" EntryId="xcb01502" xmlns="http://www.genome.jp/kegg/pathway.html">
  <Description>Vancomycin (VCM) is a glycopeptide antibiotic agent that inhibits the synthesis of peptidolgycan in the production of bacterial cell walls. It is active in most Gram-positive bacteria and acts by binding to the D-Ala-D-Ala C-terminus of pentapeptide, thus blocking the addition of subunits to the peptidoglycan backbone. The resistance to VCM was first described among enterococci in the late 1980s in Europe. Subsequently, vancomycin-resistant enteococci (VRE) have been observed in many countries. The genes encoding resistance are carried on plasmids that can tranfer themselves from cell to cell and on tranponsons that can jump from plamids to the chromosome. Up to now, at least six resistance operon types are characterized, namely VanA, VanB, VanC, VanD, VanE and VanG. The VanA and VanB operons are detected on plasmids or in the chromosome, whereas the rest are found in the chromosome. In addition, Streptomyces, which is non-pathogenic, non-glycopeptide-producing actinomycete, also shows high-level resistance to  VCM. In Streptomyces, novel genes (vanK and vanJ) are characterized with no counterparts found in the resistance clusters of pathogenic bacteria.
The expression of vancomycin resistance pathway is induced by the VanS-VanR two component system, and D-Ala-D-Lac or D-Ala-D-Ser dipsipeptides are formed in place of D-Ala-D-Ala dipeptide. Thus, VCM cannot bind to pentadepsipeptide[D-Lac] or pentadepsipeptide[D-Ser]. The D-Ala-D-Lac variation shows high levels of resistance to VCM, especially in VanA type, wheras the D-Ala-D-Ser variation shows low levels of resistance. The modified pepidoglycan can interact with cross-linking enzymes (PBPs), thus cell wall is successfully formed.</Description>
  <Name>Vancomycin resistance - Xanthomonas campestris pv. campestris 8004</Name>
  <Compound />
  <PathwayMap Key="xcb01502" Value="Vancomycin resistance" />
  <Genes>
    <hashEntry Key="xcb:XC_0232" Value="K01921 D-alanine-D-alanine ligase [EC:6.3.2.4] | (GenBank) D-alanine-D-alanine ligase A" />
    <hashEntry Key="xcb:XC_3111" Value="K07260 D-alanyl-D-alanine carboxypeptidase [EC:3.4.16.4] | (GenBank) conserved hypothetical protein" />
    <hashEntry Key="xcb:XC_3508" Value="K01921 D-alanine-D-alanine ligase [EC:6.3.2.4] | (GenBank) D-alanine-D-alanine ligase B" />
    <hashEntry Key="xcb:XC_3510" Value="K02563 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylg" />
    <hashEntry Key="xcb:XC_3512" Value="K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase [EC:2.7.8.13] | (GenBank) phospho-N-acetylm" />
    <hashEntry Key="xcb:XC_3513" Value="K01929 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase [EC:6.3.2.10] | (GenBank) UDP-N-ac" />
    <hashEntry Key="xcb:XC_3718" Value="K01775 alanine racemase [EC:5.1.1.1] | (GenBank) alanine racemase" />
    <hashEntry Key="xcb:XC_3873" Value="K08641 D-alanyl-D-alanine dipeptidase [EC:3.4.13.22] | (GenBank) D-alanyl-D-alanine dipeptidase" />
  </Genes>
  <Organism Key="xcb" Value="Xanthomonas campestris pv. campestris 8004 [GN:xcb]" />
  <KOpathway>
    <hashEntry Key="ko01502" Value="" />
  </KOpathway>
  <References>
    <Reference Journal="Clin Infect Dis 42 Suppl 1:S25-34 (2006)" PMID="16323116">
      <Authors>Courvalin P</Authors>Vancomycin resistance in gram-positive cocci.</Reference>
    <Reference Journal="Future Microbiol 7:959-78 (2012)" PMID="22913355">
      <Authors>Chancey ST</Authors>
      <Authors>Zahner D</Authors>
      <Authors>Stephens DS</Authors>Acquired inducible antimicrobial resistance in Gram-positive bacteria.</Reference>
    <Reference Journal="Trends Microbiol 4:401-7 (1996)" PMID="8899966">
      <Authors>Arthur M</Authors>
      <Authors>Reynolds P</Authors>
      <Authors>Courvalin P</Authors>Glycopeptide resistance in enterococci.</Reference>
    <Reference Journal="Clin Microbiol Rev 13:686-707 (2000)" PMID="11023964">
      <Authors>Cetinkaya Y</Authors>
      <Authors>Falk P</Authors>
      <Authors>Mayhall CG</Authors>Vancomycin-resistant enterococci.</Reference>
    <Reference Journal="Mol Microbiol 13:1065-70 (1994)" PMID="7854121">
      <Authors>Reynolds PE</Authors>
      <Authors>Depardieu F</Authors>
      <Authors>Dutka-Malen S</Authors>
      <Authors>Arthur M</Authors>
      <Authors>Courvalin P</Authors>Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.</Reference>
    <Reference Journal="J Bacteriol 178:1302-9 (1996)" PMID="8631706">
      <Authors>Evers S</Authors>
      <Authors>Courvalin P</Authors>Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583.</Reference>
    <Reference Journal="Mol Microbiol 34:341-9 (1999)" PMID="10564477">
      <Authors>Reynolds PE</Authors>
      <Authors>Arias CA</Authors>
      <Authors>Courvalin P</Authors>Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174.</Reference>
    <Reference Journal="Eur J Biochem 269:2740-6 (2002)" PMID="12047383">
      <Authors>Podmore AH</Authors>
      <Authors>Reynolds PE</Authors>Purification and characterization of VanXY(C), a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant Enterococcus gallinarum BM4174.</Reference>
    <Reference Journal="Antimicrob Agents Chemother 49:21-5 (2005)" PMID="15616270">
      <Authors>Reynolds PE</Authors>
      <Authors>Courvalin P</Authors>Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.</Reference>
    <Reference Journal="Microbiology 146 ( Pt 7):1727-34 (2000)" PMID="10878136">
      <Authors>Arias CA</Authors>
      <Authors>Weisner J</Authors>
      <Authors>Blackburn JM</Authors>
      <Authors>Reynolds PE</Authors>Serine and alanine racemase activities of VanT: a protein necessary for vancomycin resistance in Enterococcus gallinarum BM4174.</Reference>
    <Reference Journal="Adv Exp Med Biol 631:200-13 (2008)" PMID="18792691">
      <Authors>Hong HJ</Authors>
      <Authors>Hutchings MI</Authors>
      <Authors>Buttner MJ</Authors>Vancomycin resistance VanS/VanR two-component systems.</Reference>
    <Reference Journal="Mol Microbiol 50:931-48 (2003)" PMID="14617152">
      <Authors>Depardieu F</Authors>
      <Authors>Bonora MG</Authors>
      <Authors>Reynolds PE</Authors>
      <Authors>Courvalin P</Authors>The vanG glycopeptide resistance operon from Enterococcus faecalis revisited.</Reference>
    <Reference Journal="Antimicrob Agents Chemother 44:3224-8 (2000)" PMID="11036060">
      <Authors>McKessar SJ</Authors>
      <Authors>Berry AM</Authors>
      <Authors>Bell JM</Authors>
      <Authors>Turnidge JD</Authors>
      <Authors>Paton JC</Authors>Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis.</Reference>
    <Reference Journal="Antimicrob Agents Chemother 57:4470-80 (2013)" PMID="23836175">
      <Authors>Kwun MJ</Authors>
      <Authors>Novotna G</Authors>
      <Authors>Hesketh AR</Authors>
      <Authors>Hill L</Authors>
      <Authors>Hong HJ</Authors>In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall.</Reference>
    <Reference Journal="Mol Microbiol 52:1107-21 (2004)" PMID="15130128">
      <Authors>Hong HJ</Authors>
      <Authors>Hutchings MI</Authors>
      <Authors>Neu JM</Authors>
      <Authors>Wright GD</Authors>
      <Authors>Paget MS</Authors>
      <Authors>Buttner MJ</Authors>Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.</Reference>
    <Reference Journal="J Biol Chem 280:13055-61 (2005)" PMID="15632111">
      <Authors>Hong HJ</Authors>
      <Authors>Hutchings MI</Authors>
      <Authors>Hill LM</Authors>
      <Authors>Buttner MJ</Authors>The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor.</Reference>
    <Reference Journal="Mol Microbiol 59:923-35 (2006)" PMID="16420361">
      <Authors>Hutchings MI</Authors>
      <Authors>Hong HJ</Authors>
      <Authors>Buttner MJ</Authors>The vancomycin resistance VanRS two-component signal transduction system of Streptomyces coelicolor.</Reference>
    <Reference Journal="BMC Genomics 12:226 (2011)" PMID="21569315">
      <Authors>Hesketh A</Authors>
      <Authors>Hill C</Authors>
      <Authors>Mokhtar J</Authors>
      <Authors>Novotna G</Authors>
      <Authors>Tran N</Authors>
      <Authors>Bibb M</Authors>
      <Authors>Hong HJ</Authors>Genome-wide dynamics of a bacterial response to antibiotics that target the cell  envelope.</Reference>
    <Reference Journal="Nat Chem Biol 6:327-9 (2010)" PMID="20383152">
      <Authors>Koteva K</Authors>
      <Authors>Hong HJ</Authors>
      <Authors>Wang XD</Authors>
      <Authors>Nazi I</Authors>
      <Authors>Hughes D</Authors>
      <Authors>Naldrett MJ</Authors>
      <Authors>Buttner MJ</Authors>
      <Authors>Wright GD</Authors>A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor.</Reference>
  </References>
</KEGG.PathwayBrief>